Use: Labeled indications
- Use for the treatment of pinworns
Full indications and usage US FDA label
Use for the treatment of pinworns
Dosing: Adult
Dosage and administration (US label) US FDA label
Directions ■ shake well before use ■ read bottle label and package insert carefully before taking this medication ■ treat the entire household unless otherwise advised. See Warnings ■ do not repeat treatment unless directed by a doctor ■ this product can be taken any time of day, with or without meals. It may be taken alone or with milk or fruit juice.
Use of a laxative is not necessary prior to, during or after medication ■ if signs of pinworms persist after treatment, consult a doctor Weight Dosage (taken as a single dose) Less than 25 lb. or under 2 yrs.old Do not use unless directed by a doctor 25-37 lb. 1/2 teaspoonful 38-62 lb. 1 teaspoonful 63-87 lb. 1 1/2 teaspoonfuls 88-112 lb. 2 teaspoonfuls 113-137 lb. 2 1/2 teaspoonfuls 138-162 lb. 3 teaspoonfuls 163-187 lb. 3 1/2 teaspoonfuls 188 lb. and over 4 teaspoonfuls
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Suspension: 125 mg/5 mL, 250 mg/5 mL
- Tablet: 125 mg
Registered products in the Philippines
7 products registered with the Food and Drug Administration (FDA) Philippines list Pyrantel as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
All registered products7
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
CombantrinPyrantel (as embonate) | 125 mg / 5 mL SuspensionAmber Bottle x 10 mL Box of 1's | Rx | Interphil Laboratories, Inc.Philippines | JNTL CONSUMER HEALTH (PHILIPPINES) INC.Trader: Johnson & Johnson Pte Ltd | DR-X2920 | Nov 29, 2030 | |
CombantrinPyrantel (as embonate) | 125 mg TabletBlister pack of 4's (Box of 100's) | OTC | PT. Pfizer IndonesiaIndonesia | Importer: Johnson & Johnson (Philippines), Inc. | DR-769 | Oct 18, 2027 | |
DiaminticPyrantel (as Embonate) | 250 mg/5 mL Suspension (Orange Flavor)Amber Bottle with Aluminum Cap x 10 mL and 60 mL Box of 1's | Rx | Diamond Laboratories IncPhilippines | — | DR-XY16590 | Apr 4, 2031 | |
GelminthicPyrantel (as Embonate) | 125 mg/5 mL SuspensionAmber Glass Bottle x 10 mL (Box of 1's) | OTC | Diamond Laboratories Inc.Philippines | Trader: Vonnace Pharmaceuticals Corporation | DR-XY20004 | Mar 23, 2027 | |
NonePyrantel Pamoate | 250 mg/5 mL SuspensionAmber Glass Bottle x 60 mL Box of 1's | OTC | Drugmakers Laboratories Inc.Philippines | — | DRP-5524 | Oct 1, 2028 | |
NonePyrantel Pamoate | 250 mg/5 mL SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | OTC | Drugmaker’s Laboratories Inc.Philippines | TGP Pharma Inc. | DRP-5524-01 | Oct 1, 2028 | |
PypedPyrantel (as Pamoate) | 250 mg/5 mL SuspensionAmber Glass Bottle x 10 mL Box of 1's; Amber Glass Bottle x 60 mL Box of 1's | OTC | Drugmaker's Laboratories, Inc.Philippines | Trader: Terramedic, Inc. | DR-XY31621 | Apr 12, 2028 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Warnings/Precautions
Warnings and precautions (US label) US FDA label
Warnings Do not exceed recommended dosage
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- U.S. Food and Drug Administration. pinworm treatment · BIONPHARMA INC. [US FDA-approved label, version 2, January 23, 2026]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3cf96d04-e8bc-31af-e063-6294a90a0db8
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .